ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).
Company Details
- Employees
- 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.rerxtherapeutics.com
- Keywords
- Corona.
Rerx Therapeutics Questions
Rerx Therapeutics's website is http://www.rerxtherapeutics.com
Rerx Therapeutics's LinkedIn profile is https://www.linkedin.com/company/rerxtherapeutics
Rerx Therapeutics has
3 employees.
View email and phone details for 3
employees at Rerx Therapeutics.
Rerx Therapeutics's industry is
Biotechnology Research
Rerx Therapeutics's top competitors are
Reviva Pharmaceuticals,
Enumera Molecular,
Spruce Biosciences,
Lynx Dx,
Acuvia,
Hdax Therapeutics,
Berkeley Business Society,
Endometrics,
Elenae Therapeutics, Inc.,
Tap Pharmaceuticals Ag.
Rerx Therapeutics's categories are Biotechnology Research
